Max Duesberg, MD

Internal Medicine
Santa Clara Valley Medical Center

Poster(s):

• (28-RES) Hyperprogressive Disease Following Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma
  Thursday, October 9, 2025